Tango Therapeutics (TNGX) Accumulated Depreciation & Amortization (2020 - 2025)
Historic Accumulated Depreciation & Amortization for Tango Therapeutics (TNGX) over the last 6 years, with Q3 2025 value amounting to $10.1 million.
- Tango Therapeutics' Accumulated Depreciation & Amortization rose 2992.38% to $10.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.1 million, marking a year-over-year increase of 2992.38%. This contributed to the annual value of $8.4 million for FY2024, which is 3963.93% up from last year.
- Tango Therapeutics' Accumulated Depreciation & Amortization amounted to $10.1 million in Q3 2025, which was up 2992.38% from $9.6 million recorded in Q2 2025.
- Tango Therapeutics' Accumulated Depreciation & Amortization's 5-year high stood at $10.1 million during Q3 2025, with a 5-year trough of $2.3 million in Q3 2021.
- In the last 5 years, Tango Therapeutics' Accumulated Depreciation & Amortization had a median value of $5.4 million in 2023 and averaged $5.7 million.
- Per our database at Business Quant, Tango Therapeutics' Accumulated Depreciation & Amortization skyrocketed by 6815.9% in 2023 and then surged by 2992.38% in 2025.
- Quarter analysis of 5 years shows Tango Therapeutics' Accumulated Depreciation & Amortization stood at $2.5 million in 2021, then soared by 45.55% to $3.7 million in 2022, then soared by 62.7% to $6.0 million in 2023, then soared by 39.64% to $8.4 million in 2024, then rose by 20.29% to $10.1 million in 2025.
- Its Accumulated Depreciation & Amortization was $10.1 million in Q3 2025, compared to $9.6 million in Q2 2025 and $9.0 million in Q1 2025.